Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B.

Am J Respir Crit Care Med. 2006 Jul 1;174(1):84-93. Epub 2006 Apr 7.

PMID:
16603606
[PubMed - indexed for MEDLINE]
2.

Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.

Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J.

Respirology. 2011 Jul;16(5):819-24. doi: 10.1111/j.1440-1843.2011.01978.x.

PMID:
21507143
[PubMed - indexed for MEDLINE]
Free Article
3.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B.

Lancet. 2004 Feb 21;363(9409):600-7.

PMID:
14987884
[PubMed - indexed for MEDLINE]
4.

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schönenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Müller B; ProHOSP study group.

BMC Health Serv Res. 2007 Jul 5;7:102.

PMID:
17615073
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.

Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR, Nicholson KG, Brightling CE.

Chest. 2011 Jun;139(6):1410-8. doi: 10.1378/chest.10-1747. Epub 2010 Oct 28.

PMID:
21030489
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.

Jereb M, Kotar T.

Wien Klin Wochenschr. 2006 Apr;118(5-6):170-4.

PMID:
16773483
[PubMed - indexed for MEDLINE]
7.

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Müller C, Huber P, Müller B, Tamm M.

Chest. 2007 Jan;131(1):9-19.

PMID:
17218551
[PubMed - indexed for MEDLINE]
8.

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study.

Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M.

Eur Respir J. 2009 Dec;34(6):1364-75. doi: 10.1183/09031936.00053209. Epub 2009 Sep 24.

PMID:
19797133
[PubMed - indexed for MEDLINE]
Free Article
9.

Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.

Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I.

Chest. 2005 Oct;128(4):2223-9.

PMID:
16236878
[PubMed - indexed for MEDLINE]
10.

Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.

Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Périat P, Bucher HC, Christ-Crain M.

Arch Intern Med. 2008 Oct 13;168(18):2000-7; discussion 2007-8. doi: 10.1001/archinte.168.18.2000.

PMID:
18852401
[PubMed - indexed for MEDLINE]
11.

Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.

Cunha BA.

Scand J Infect Dis. 2009;41(10):782-4. doi: 10.1080/00365540903147035. No abstract available.

PMID:
19681019
[PubMed - indexed for MEDLINE]
12.

[The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].

Long W, Deng XQ, Tang JG, Xie J, Zhang YC, Zhang Y, Gao YY, Lu G.

Zhonghua Nei Ke Za Zhi. 2009 Mar;48(3):216-9. Chinese.

PMID:
19576090
[PubMed - indexed for MEDLINE]
13.

Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.

Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

Chest. 2010 Jul;138(1):121-9. doi: 10.1378/chest.09-2920. Epub 2010 Mar 18.

PMID:
20299634
[PubMed - indexed for MEDLINE]
14.

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.

Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC; GenIMS Investigators.

Ann Emerg Med. 2008 Jul;52(1):48-58.e2. doi: 10.1016/j.annemergmed.2008.01.003. Epub 2008 Mar 17.

PMID:
18342993
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.

Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, Bosis S, Pinzani R, Principi N.

Respir Med. 2011 Dec;105(12):1939-45. doi: 10.1016/j.rmed.2011.09.003. Epub 2011 Sep 29.

PMID:
21959024
[PubMed - indexed for MEDLINE]
Free Article
16.

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group.

JAMA. 2009 Sep 9;302(10):1059-66. doi: 10.1001/jama.2009.1297.

PMID:
19738090
[PubMed - indexed for MEDLINE]
17.

Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.

Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, van der Meer JW.

Clin Infect Dis. 2007 Apr 1;44(7):931-41. Epub 2007 Feb 20.

PMID:
17342644
[PubMed - indexed for MEDLINE]
Free Article
18.

Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.

Ramírez P, Ferrer M, Martí V, Reyes S, Martínez R, Menéndez R, Ewig S, Torres A.

Crit Care Med. 2011 Oct;39(10):2211-7. doi: 10.1097/CCM.0b013e3182257445.

PMID:
21705887
[PubMed - indexed for MEDLINE]
19.

The value of procalcitonin level in community-acquired pneumonia in the ED.

Park JH, Wee JH, Choi SP, Oh SH.

Am J Emerg Med. 2012 Sep;30(7):1248-54. doi: 10.1016/j.ajem.2011.08.009. Epub 2011 Oct 24.

PMID:
22030193
[PubMed - indexed for MEDLINE]
20.

Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis.

Hedlund J, Hansson LO.

Infection. 2000 Mar-Apr;28(2):68-73.

PMID:
10782390
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk